Heath, P T, Galiza, E P, Baxter, D N, Boffito, M, Browne, D, Burns, F, Chadwick, D R, Clark, R, Cosgrove, C A, Galloway, J, Goodman, A L, Heer, A, Higham, A, Iyengar, S, Jeanes, C, Kalra, P A, Kyriakidou, C, Bradley, J M, Munthali, C, Minassian, A M, McGill, F, Moore, P, Munsoor, I, Nicholls, H, Osanlou, O, Packham, J, Pretswell, C H, Francisco Ramos, A S, Saralaya, D, Sheridan, R P, Smith, R, Soiza, R L, Swift, P A, Thomson, E C, Turner, J, Viljoen, M E, Fries, L, Cho, I, McKnight, I, Glenn, G, Rivers, E J, Robertson, A, Alves, K, Smith, K & Toback, S 2023, ' Safety and efficacy of the NVX-CoV2373 COVID-19 vaccine at completion of the placebo-controlled phase of a randomized controlled trial ', Clinical Infectious Diseases, vol. 76, no. 3, pp. 398–407 . https://doi.org/10.1093/cid/ciac803